Liver Failure

Gastroenterology
3
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
1
0
2
0
0
0
Early DiscoveryClinical DevelopmentMarket

Competitive Landscape

2 companies ranked by most advanced pipeline stage

Veloxis Pharmaceuticals
2 programs
2
LCP -TacroPhase 21 trial
LCP TacroPhase 21 trial
Active Trials
NCT00772148CompletedEst. May 2010
NCT00608244CompletedEst. Jun 2008
US WorldMeds
US WorldMedsKY - Louisville
1 program
1
Lofexidine HydrochloridePhase 11 trial
Active Trials
NCT02318836Completed24Est. Oct 2014

Trial Timeline

Clinical trial activity over time

2021
2022
2023
2024
2025
2026
Veloxis PharmaceuticalsLCP -Tacro
Veloxis PharmaceuticalsLCP Tacro
US WorldMedsLofexidine Hydrochloride

Clinical Trials (3)

Total enrollment: 24 patients across 3 trials

Pharmacokinetics of LCP-Tacro™ Once Daily and Prograf® Twice A Day in Adult De Novo Liver Transplant Patients

Start: Oct 2008Est. completion: May 2010
Phase 2Completed

Pharmacokinetics of LCP-Tacro in Stable Liver Transplant Patients

Start: Nov 2007Est. completion: Jun 2008
Phase 2Completed
NCT02318836US WorldMedsLofexidine Hydrochloride

Single-Dose Pharmacokinetics and Safety of Oral Lofexidine in Hepatically-Impaired Subjects

Start: Jun 2014Est. completion: Oct 201424 patients
Phase 1Completed

Related Jobs in Gastroenterology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

2 companies competing in this space